Alicia O’Neill Team MMRF

Alicia was on the 2017 Road to Victories Team’s ride from LA to Flagstaff and works for the MMRF. She has been involved with the Road to Victories program since its inception. “Working for the MMRF for over ten years, I have come to know so many patients…so riding to raise funds to help fast track breakthrough research has become personal”. Alicia is relatively new to cycling, and enjoys joining these teams each year to help raise awareness and funds for research.

She didn’t expect to be at her daughter’s wedding
Alicia O'Neill
5 years ago, when she heard her doctor say, “You have multiple myeloma”, the doctor also used these words: “incurable cancer”. She was told she had only a few years…
Read More
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More